These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5082383)

  • 21. Pioglitazone trial for NASH: results show promise.
    Lang L
    Gastroenterology; 2007 Mar; 132(3):836-8. PubMed ID: 17383411
    [No Abstract]   [Full Text] [Related]  

  • 22. TNF-alpha as therapeutic target in NASH: tried, but not yet proven.
    Chitturi S; Farrell GC
    J Gastroenterol Hepatol; 2007 May; 22(5):613-4. PubMed ID: 17444846
    [No Abstract]   [Full Text] [Related]  

  • 23. [Contribution of liver biopsy and serology of hepatitis C virus to the diagnosis of a moderate and prolonged elevation of aminotransferases].
    Dao T; Lecointe I; Galateau F; Freymuth F; Rideau A; Verwaerde JC; Valla A
    Gastroenterol Clin Biol; 1993; 17(1):37-43. PubMed ID: 8467969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid droplets in fatty liver. An electron microscopic study on ultrasections obtained by a new cutting technique.
    Petersen P
    Acta Pathol Microbiol Scand A; 1974 Mar; 82(2):255-63. PubMed ID: 4133490
    [No Abstract]   [Full Text] [Related]  

  • 25. Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C.
    Giannini E; Botta F; Cataldi A; Tenconi GL; Ceppa P; Barreca T; Testa R
    Hepatogastroenterology; 1999; 46(28):2422-5. PubMed ID: 10522010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exchange transfusions for intractable hepatic coma. Successful treatment of a patient with alcoholic hepatitis.
    Szwed JJ; Grisell TW; Mendenhall CL
    Arch Intern Med; 1969 Apr; 123(4):441-4. PubMed ID: 5778124
    [No Abstract]   [Full Text] [Related]  

  • 27. Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.
    Hookman P; Barkin JS
    Am J Gastroenterol; 2003 Sep; 98(9):2093-7. PubMed ID: 14499793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonalcoholic fatty liver disease liver fat score and fat equation to predict and quantitate hepatic steatosis: promising but not prime time!
    Chalasani N
    Gastroenterology; 2009 Sep; 137(3):772-5. PubMed ID: 19638269
    [No Abstract]   [Full Text] [Related]  

  • 29. Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months.
    Keshishian A; Zahriya K; Willes EB
    Obes Surg; 2005; 15(10):1418-23. PubMed ID: 16354521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic steatosis and fibrosis in chronic hepatitis C in Taiwan.
    Hsieh MH; Lee LP; Hsieh MY; Tsai KB; Huang JF; Hou NJ; Chen SC; Lin ZY; Hsieh MY; Wang LY; Dai CY; Chuang WL; Yu ML
    Jpn J Infect Dis; 2007 Nov; 60(6):377-81. PubMed ID: 18032828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Attempt to establish a histological prognosis of severe acute hepatitis].
    Scotto J; Lageron A; Caroli J
    Ann Anat Pathol (Paris); 1970; 15(1):105-14. PubMed ID: 5443945
    [No Abstract]   [Full Text] [Related]  

  • 32. [Possibilities and limits of the morphometric point system for the determination of lipid content in liver biopsy sections].
    Kremer GJ; Kössling FK; Lange HJ; Victor N
    Klin Wochenschr; 1969 Sep; 47(17):896-902. PubMed ID: 4909975
    [No Abstract]   [Full Text] [Related]  

  • 33. Acute fatty liver of pregnancy in a patient with chronic active hepatitis and associated hepatocyte alpha 1-antitrypsin inclusions.
    Minton D; Yancey MK; Dolson DJ; Duff P
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):819-23. PubMed ID: 8469484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathologic assessment of non-alcoholic fatty liver disease.
    Bondini S; Kleiner DE; Goodman ZD; Gramlich T; Younossi ZM
    Clin Liver Dis; 2007 Feb; 11(1):17-23, vii. PubMed ID: 17544969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Regenerative tendencies in the alcoholic fatty liver under diet. Change in the dietary fat content].
    Irsigler K; Kryspin-Exner K; Mildschuh W
    Acta Hepatosplenol; 1970; 17(2):103-10. PubMed ID: 5524290
    [No Abstract]   [Full Text] [Related]  

  • 36. Pathogenesis of NASH: animal models.
    London RM; George J
    Clin Liver Dis; 2007 Feb; 11(1):55-74, viii. PubMed ID: 17544972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unexpected liver failure after right hemihepatectomy for colorectal liver metastasis due to chemotherapy-associated steato-hepatitis: time for routine preoperative liver biopsy?
    Sotiropoulos GC; Saner FH; Molmenti EP; Radtke A; Timm S; Baba HA; Paul A; Lang H
    Int J Colorectal Dis; 2009 Feb; 24(2):241. PubMed ID: 18762953
    [No Abstract]   [Full Text] [Related]  

  • 38. Surgically resected hepatocellular carcinomas in patients with non-alcoholic steatohepatitis.
    Maeda T; Hashimoto K; Kihara Y; Ikegami T; Ishida T; Aimitsu S; Fujiwara M
    Hepatogastroenterology; 2008; 55(85):1404-6. PubMed ID: 18795699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Correlation between liver biopsy and clinical tests].
    Anzai T
    Rinsho Byori; 1971 Jul; 19(7):439-45. PubMed ID: 5106939
    [No Abstract]   [Full Text] [Related]  

  • 40. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes.
    Larter CZ; Yeh MM; Williams J; Bell-Anderson KS; Farrell GC
    J Hepatol; 2008 Sep; 49(3):407-16. PubMed ID: 18534710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.